Breaking News Headlines Today | Ground News

See every side of every news story

endpoints.news image

News from endpoints.news

endpoints.news’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

endpoints.news’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about endpoints.news

Where is endpoints.news located?endpoints.news's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top endpoints.news News

Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal — REUTERS / ixx511

Tylenol · United States

Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal

62% Center coverage: 186 sources

FDA's Top Drug Regulator Resigns After Federal Officials Probe 'Serious Concerns' — REUTERS / pwu404

FDA · United States

FDA's Top Drug Regulator Resigns After Federal Officials Probe 'Serious Concerns'

63% Center coverage: 65 sources

The head of the Food and Drug Administration’s drug center abruptly resigned Sunday amid concerns about his personal conduct See the Story

Lilly to build $3 billion Dutch plant to boost weight-loss pill production — REUTERS / pwu404

Eli Lilly · Netherlands

Lilly to build $3 billion Dutch plant to boost weight-loss pill production

50% Center coverage: 10 sources

Eli Lilly said on Monday it plans to build a new $3 billion manufacturing plant in the Netherlands to expand the production capacity for its keenly watched experimental weight-loss pill, orforglipron, and other oral medicines.See the Story

Breaking News Topics Related to endpoints.news